BioNexus Gene Lab invests $450K in color paste production; signs MOU with Shenzhen Rongguang Health

BioNexus Gene Lab Corp

Chemrex invests RM 2M (~$450K) to produce fine-quality color paste for composite industrial customers; operations start Sept 2024.
In-house production expected to increase profit margins, improve quality control, and enable competitive pricing.
Company plans additional production facilities in the Middle East and Vietnam; bulk purchasing synergies.
MOU with Shenzhen Rongguang Health Group aims to expand cancer screening, precision medicine, and preventative healthcare in Asia.
MRNA Scientific subsidiary will lead cancer screening expansion with advanced genomic testing across Southeast Asia and China.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.